2HAMM C W, BASSAND J P, AGEWELL S,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2011, 32(23): 2999-3054.
3LEVINE G N, BATES E R, BLANKENSHIP J C, et al. 2011 ACCF/AHA/SCAI Guideline for Pereutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [J ]. Circulation, 2011, 124(23) : 2574-2609.
4CAMM A J, KIRCHHOF P, LIP G Y, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC) [J]. Eur Heart J, 2010, 31(19): 2369- 2429.
5WIVIOTT S D, BRAUNWALD E, MCCABE C H, et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stentiug in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial[J]. Lancet, 2008, 371 (9621) : 1353-1363.
6GREINACHER A, WARKENTIN T E. The direct thrombin inhibitor hirudin [ J ]. Thromb Haemost, 2008, 99 (5) : 819 - 829.
7LASSAR T A, SIMON D I, CROCE K. Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing[J]. Rev Cardiovasc Med, 2011, 12(Suppl 1) : S23-33.
8HUSTED S, VAN GIEZEN J J. Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist [J]. Cardiovasc Ther, 2009, 27(4): 259-274.
8Kushner FG,Hand M,Smith SC Jr,et al.2009 Focused Updates:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update):A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2009,54:2205-2241.
9Vila PM,Zafar MU,Badimon JJ.Platelet reactivity and nonresponse to dual antiplatelet therapy:a review.Platelets,2009,20:531-538.
10Salzman EW,Chambers DA,Neri LL.Possible mechanism of aggregation of blood platelets by adenosine diphosphate.Nature,1966,210:167-169.
